Amarantus Bioscience Holdings, Inc. — Form D

Amarantus Bioscience Holdings, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-12. The offering totals $1.5M, of which $300K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Gerald CommissiongDirectorSan Francisco, CA
John CommissiongDirectorSan Francisco, CA
Robert HarrisDirectorPotomac, MD
Donald HuffmanDirectorSan Francisco, CA
Steven SpenceDirectorSan Francisco, CA
Gerald CommissiongExecutive OfficerSan Francisco, CA
John CommissiongExecutive OfficerSan Francisco, CA
David LoweDirectorWalnut Creek, CA
Robert FarrellExecutive OfficerNew York, NY
Iain RossDirectorLondon, X0
MARC FAERBERExecutive OfficerSANTA CRUZ, CA
Robert L HarrisDirectorDallas, TX
Robert E HarrisDirectorSUNNYVALE, CA
Marc E FaerberExecutive OfficerSUNNYVALE, CA
Gerald E CommissiongDirectorSUNNYVALE, CA
Gerald E CommissiongExecutive OfficerSUNNYVALE, CA
Mark E BenedykDirectorSUNNYVALE, CA
Dr. John W CommissiongDirectorSUNNYVALE, CA
Dr. John W CommissiongExecutive OfficerSUNNYVALE, CA
Mark L BenedykDirectorSunnyvale, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2014-11-17D$3.0M$3.0M
2013-09-13D$5.0M$1.4M
2013-08-28D$1.3M$1.3M

More